
Boston Scientific: Global developer and marketer of minimally invasive medical devices.
Boston Scientific is a pioneer of minimally invasive surgery with a culture built on caring, high performance, diversity, meaningful innovation, winning spirit, and global collaboration. That heritage supports leadership across many specialties rather than dependence on one franchise.
Durable scale reinforces the edge with about 59,000 employees across six continents, 2.0 billion dollars of annual research investment, and about 20 billion dollars in net sales. Global reach plus sustained research spending keeps the pipeline advancing.
Source: bostonscientific.com
Boston Scientific advances science for life by addressing major healthcare challenges with minimally invasive solutions. The mission centers on giving patients more time, more quality of life, and more moments with the people they love.
Scale is global with about 59,000 employees across six continents, more than 48 million patients treated each year, 2.0 billion dollars invested in research and development, and about 20 billion dollars in net sales. All figures reflect 2025 company data.
Source: bostonscientific.com
Boston Scientific offers a broad minimally invasive portfolio spanning interventional cardiology, electrophysiology, structural heart, gastroenterology, urology, pelvic health, pain management, and vascular care. Featured platforms include the FARAPULSE pulsed field ablation system and cardiac resynchronization therapy systems.
Products are organized by specialty and category for healthcare professionals, with online ordering, training through EDUCARE, and literature such as directions for use and MRI compatibility resources. The lineup supports diagnosis, intervention, rhythm management, and chronic care.
Source: bostonscientific.com